Schedule 13G ownership disclosure

CIDARA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 171757206

Event date: 2025-07-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Paradigm BioCapital Advisors LP

    Shares: 1,128,613.00 · Class: 5.6%

  • Paradigm BioCapital Advisors GP LLC

    Shares: 1,128,613.00 · Class: 5.6%

  • Senai Asefaw, M.D.

    Shares: 1,128,613.00 · Class: 5.6%

  • Paradigm BioCapital International Fund Ltd.

    Shares: 994,177.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-072167
Form type
SCHEDULE 13G
Filer
Cidara Therapeutics, Inc.
CIK
CIK 1610618
Filed
Jul 30, 2025
Reporting period
Jul 23, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub